Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00618501
What this trial is testing

Imatinib Mesylate and Combination Chemotherapy With or Without a Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
Asan Medical Center 50
Early research (Phase 1)Study completedNCT00352677
What this trial is testing

Safety and Tolerability Study of INNO-406 to Treat Chronic Myeloid Leukemia or Acute Lymphocytic Leukemia

Who this might be right for
Chronic Myeloid LeukemiaAcute Lymphocytic Leukemia
CytRx 100
Early research (Phase 1)Study completedNCT00807677
What this trial is testing

Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myelogenous Leukemia+9 more
Millennium Pharmaceuticals, Inc. 31
Testing effectiveness (Phase 2)Ended earlyNCT00006092
What this trial is testing

Arsenic Trioxide for Induction Therapy of Adult Patients With Leukemia

Who this might be right for
Leukemia
H. Lee Moffitt Cancer Center and Research Institute 2
Large-scale testing (Phase 3)Active Not RecruitingNCT03589326
What this trial is testing

Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia

Who this might be right for
Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)
Takeda 245
Early research (Phase 1)Study completedNCT00816283
What this trial is testing

Dasatinib and Vorinostat in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Acute Lymphoblastic Leukemia

Who this might be right for
Leukemia
City of Hope Medical Center 5
Early research (Phase 1)Study completedNCT00316953
What this trial is testing

Dasatinib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Did Not Respond to Imatinib Mesylate

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaBlastic Phase Chronic Myelogenous LeukemiaChildhood Chronic Myelogenous Leukemia+5 more
National Cancer Institute (NCI) 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT04329325
What this trial is testing

Blinatumomab and Tyrosine Kinase Inhibitor Therapy in People With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaPhiladelphia Chromosome-Positive
Memorial Sloan Kettering Cancer Center 17
Early research (Phase 1)Study completedNCT01159028
What this trial is testing

Clinical Trial of BP1001 (L-Grb-2 Antisense Oligonucleotide) in CML, AML, ALL & MDS

Who this might be right for
Recurrent Adult Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome+1 more
Bio-Path Holdings, Inc. 60
Testing effectiveness (Phase 2)Looking for participantsNCT06124157
What this trial is testing

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Who this might be right for
B Acute Lymphoblastic Leukemia
National Cancer Institute (NCI) 222
Testing effectiveness (Phase 2)Study completedNCT01724879
What this trial is testing

Study of Frontline Dasatinib Plus Chemotherapy in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (PH+ALL)

Who this might be right for
Philadelphia Positive Acute Lymphoblastic Leukemia
Goethe University 19
Large-scale testing (Phase 3)Active Not RecruitingNCT04722848
What this trial is testing

Sequential Treatment With Ponatinib and Blinatumomab vs Chemotherapy and Imatinib in Newly Diagnosed Adult Ph+ ALL

Who this might be right for
Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)ALL, AdultPhiladelphia-Positive ALL
Gruppo Italiano Malattie EMatologiche dell'Adulto 236
Testing effectiveness (Phase 2)Study completedNCT02228096
What this trial is testing

Study of Efficacy and Safety of CTL019 in Pediatric ALL Patients

Who this might be right for
B-cell Acute Lymphoblastic LeukemiaRelapsed B-cell Acute Lymphoblastic LeukemiaRefractory B-cell Acute Lymphoblastic Leukemia
Novartis Pharmaceuticals 75
Not applicableStudy completedNCT00068523
What this trial is testing

Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+3 more
Case Comprehensive Cancer Center 10
Not applicableUnknownNCT01376427
What this trial is testing

Treatment of Acute Lymphoblastic Leukemia Ph '(BCR / ABL) Positive Patients Aged > 55 Years

Who this might be right for
Acute Lymphoblastic Leukemia Ph Positive
PETHEMA Foundation 100
Testing effectiveness (Phase 2)Study completedNCT00384228
What this trial is testing

A Phase l/ll Study of AMN107 in Adult Patients With Glivec-intolerant CML or Relapsed-refractory Ph+ALL

Who this might be right for
Chronic Myelogenous LeukemiaAcute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)
Novartis Pharmaceuticals 42
Large-scale testing (Phase 3)Study completedNCT02272777
What this trial is testing

Imatinib and Nilotinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase

Who this might be right for
Leukemia
Novartis Pharmaceuticals 225
Testing effectiveness (Phase 2)WithdrawnNCT04845035
What this trial is testing

Pediatric-Inspired Chemotherapy Plus Tyrosine Kinase Inhibitor in Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
University of Michigan Rogel Cancer Center
Testing effectiveness (Phase 2)UnknownNCT01361438
What this trial is testing

De Novo Adult Philadelphia Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) Patients

Who this might be right for
ALL Ph Positive
Gruppo Italiano Malattie EMatologiche dell'Adulto 60
Testing effectiveness (Phase 2)Study completedNCT00390793
What this trial is testing

Combination Chemotherapy and Dasatinib in Treating Participants With Philadelphia Positive or BCR-ABL Positive Acute Lymphoblastic Leukemia.

Who this might be right for
Acute Lymphoblastic LeukemiaBCR-ABL1 Fusion Protein ExpressionBlast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive+3 more
M.D. Anderson Cancer Center 107
Next Page